Wang et al. and Chu et al. indicated that rs744154 was in LD with -357A > C polymorphism in the ERCC4 promoter, then altered the expression of ERCC4 mRNA and protein, and finally affected the susceptibility to bladder and gastric cancer (40, 41). Here, ERCC4 is linked to gastric cancer.